Finch Therapeutics (FNCH)

Navigating the microbiome.

Finch Therapeutics (FNCH - $652M) is a microbiome therapeutics company developing a range of treatments. It’s lead candidate CP101 is an orally administered pill that was fast tracked by the FDA for the treatment of C. difficile.

The microbiome is an exciting area of medical research that could help treat digestive problems, auto-immune diseases, skin co…